Literature DB >> 20433913

Dendrimer toxicity: Let's meet the challenge.

Keerti Jain1, Prashant Kesharwani, Umesh Gupta, N K Jain.   

Abstract

Dendrimers are well-defined, versatile polymeric architecture with properties resembling biomolecules. Dendritic polymers emerged as outstanding carrier in modern medicine system because of its derivatisable branched architecture and flexibility in modifying it in numerous ways. Dendritic scaffold has been found to be suitable carrier for a variety of drugs including anticancer, anti-viral, anti-bacterial, antitubercular etc., with capacity to improve solubility and bioavailability of poorly soluble drugs. In spite of extensive applicability in pharmaceutical field, the use of dendrimers in biological system is constrained because of inherent toxicity associated with them. This toxicity is attributed to the interaction of surface cationic charge of dendrimers with negatively charged biological membranes in vivo. Interaction of dendrimers with biological membranes results in membrane disruption via nanohole formation, membrane thinning and erosion. Dendrimer toxicity in biological system is generally characterized by hemolytic toxicity, cytotoxicity and hematological toxicity. To minimize this toxicity two strategies have been utilized; first, designing and synthesis of biocompatible dendrimers; and second, masking of peripheral charge of dendrimers by surface engineering. Biocompatible dendrimers can be synthesized by employing biodegradable core and branching units or utilizing intermediates of various metabolic pathways. Dendrimer biocompatibility has been evaluated in vitro and in vivo for efficient presentation of biological performance. Surface engineering masks the cationic charge of dendrimer surface either by neutralization of charge, for example PEGylation, acetylation, carbohydrate and peptide conjugation; or by introducing negative charge such as half generation dendrimers. Neutral and negatively charged dendrimers do not interact with biological environment and hence are compatible for clinical applications as elucidated by various studies examined in this review. Chemical modification of the surface is an important strategy to overcome the toxicity problems associated with the dendrimers. The present review emphasizes on the approaches available to overcome the cationic toxicity inherently associated with the dendrimers. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20433913     DOI: 10.1016/j.ijpharm.2010.04.027

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  93 in total

1.  Novel monodisperse PEGtide dendrons: design, fabrication, and evaluation of mannose receptor-mediated macrophage targeting.

Authors:  Jieming Gao; Peiming Chen; Yashveer Singh; Xiaoping Zhang; Zoltan Szekely; Stanley Stein; Patrick J Sinko
Journal:  Bioconjug Chem       Date:  2013-08-21       Impact factor: 4.774

2.  Surface-engineered dendrimeric nanoconjugates for macrophage-targeted delivery of amphotericin B: formulation development and in vitro and in vivo evaluation.

Authors:  Keerti Jain; Ashwni Kumar Verma; Prabhat Ranjan Mishra; Narendra Kumar Jain
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

3.  Functionalized dendrimer-based delivery of angiotensin type 1 receptor siRNA for preserving cardiac function following infarction.

Authors:  Jie Liu; Catherine Gu; E Bernadette Cabigas; Karl D Pendergrass; Milton E Brown; Ying Luo; Michael E Davis
Journal:  Biomaterials       Date:  2013-02-19       Impact factor: 12.479

4.  Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging.

Authors:  Serhat Gündüz; Tanja Savić; Đorđe Toljić; Goran Angelovski
Journal:  J Vis Exp       Date:  2016-12-04       Impact factor: 1.355

5.  Graphene-Dendrimer Nanostars for Targeted Macrophage Overexpression of Metalloproteinase 9 and Hepatic Fibrosis Precision Therapy.

Authors:  Pedro Melgar-Lesmes; Aureli Luquero; Marina Parra-Robert; Adriana Mora; Jordi Ribera; Elazer R Edelman; Wladimiro Jiménez
Journal:  Nano Lett       Date:  2018-08-16       Impact factor: 11.189

6.  Neuroprotective Effect of New Nanochelating-Based Nano Complex, ALZc3, Against Aβ (1-42)-Induced Toxicity in Rat: a Comparison with Memantine.

Authors:  Ramin Karimi-Sales; Mehrafarin Ashiri; Maryam Hafizi; Somayeh Kalanaky; Amir Hossein Maghsoudi; Saideh Fakharzadeh; Nader Maghsoudi; Mohammad Hassan Nazaran
Journal:  Pharm Res       Date:  2020-02-04       Impact factor: 4.200

Review 7.  Recent perspectives on the delivery of biologics to back of the eye.

Authors:  Mary Joseph; Hoang M Trinh; Kishore Cholkar; Dhananjay Pal; Ashim K Mitra
Journal:  Expert Opin Drug Deliv       Date:  2016-09-06       Impact factor: 6.648

Review 8.  Health implications of engineered nanoparticles in infants and children.

Authors:  Song Tang; Mao Wang; Kaylyn E Germ; Hua-Mao Du; Wen-Jie Sun; Wei-Min Gao; Gregory D Mayer
Journal:  World J Pediatr       Date:  2015-08-08       Impact factor: 2.764

9.  Novel aldehyde-terminated dendrimers; synthesis and cytotoxicity assay.

Authors:  Aliasghar Hamidi; Simin Sharifi; Soodabeh Davaran; Saeed Ghasemi; Yadollah Omidi; Mohammad-Reza Rashidi
Journal:  Bioimpacts       Date:  2012-05-27

10.  Recent advances in targeted drug delivery approaches using dendritic polymers.

Authors:  Jason Bugno; Hao-jui Hsu; Seungpyo Hong
Journal:  Biomater Sci       Date:  2014-12-11       Impact factor: 6.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.